Reflect on your last visit to a healthcare provider. Did you feel like a valued partner in your care? Now, consider participating in a research study with an unapproved potential treatment. How has ...

Are you a small business owner or entrepreneur eager to strengthen your team and retain top talent? Join Innovate Carolina Junction on November 13 for an insightful workshop on employee retention ...

Gilero, a medical device manufacturer with two sites in North Carolina, is expanding to a third site in the state -- a new 60 ...

Come gain and share insights while growing your network in NC's ag tech community. This event is free for WIA members, but open to all. Thank you to Syngenta for sponsoring the Fall meet-up.

The first-ever point-of-care instrument for qualitatively detecting fentanyl in human urine has been cleared for use by the U.S. Food Drug Administration and will be distributed in the United States ...

David Reeser is one of the millions of Americans whose life has been changed by the ever-evolving, fast-growing epidemic of ...

Join moderator Kelly Parsons at UNC for an insightful conversation with three industry veterans: Jaap Schut, Pepper Landson, and Chris Rusconi. Each veteran has successfully transformed groundbreaking ...

Charles E. Hamner, Jr., Ph.D., a former president and CEO of the North Carolina Biotechnology Center and a longtime advocate for life sciences in the state, has received the 2024 High Flyer Champion ...

The Triangle is known as a hotbed for innovation, thanks in large part to the partnerships between multiple stakeholders, including universities, investors and ecosystem support organizations. In that ...

Radiopharmaceuticals, once a very niche drug class, are now on the brink of transforming cancer treatment and diagnostics, and North Carolina is at the heart of this change. These radioactive drugs ...

Research Triangle Park-based Opus Genetics, a clinical-stage gene therapy company devoted to treating inherited retinal diseases, has been acquired by a small ophthalmic biopharmaceutical firm with ...

SCHOTT Pharma USA, Inc., part of SHOTT Pharma AG, a global specialty glass manufacturer based in Germany, plans to invest $371 million over the next five years to build a new production facility in ...